Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Juan Pasquau-Liaño"'
Autor:
Svetlana Sadyrbaeva-Dolgova, Ricardo García-Fumero, Manuela Exposito-Ruiz, Juan Pasquau-Liaño, Alberto Jiménez-Morales, Carmen Hidalgo-Tenorio
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Colistimethate sodium (CMS) is the inactive prodrug of colistin, CMS has a narrow antibacterial spectrum with concentration-dependent bactericidal activity against multidrug-resistant gram-negative bacteria, including Pseudomonas aeruginosa
Externí odkaz:
https://doaj.org/article/bdd44f0e7d0a4ac18c8138844a308ea1
Autor:
Svetlana Sadyrbaeva-Dolgova, Pilar Aznarte-Padial, Juan Pasquau-Liaño, Manuela Expósito-Ruiz, Miguel Ángel Calleja Hernández, Carmen Hidalgo-Tenorio
Publikováno v:
International Journal of Infectious Diseases, Vol 85, Iss , Pp 80-87 (2019)
Objective: The aim of this study was to evaluate the safety and efficacy of de-escalation in patients under treatment with carbapenems and its impact on clinical outcomes. Methods: A prospective observational study was conducted for 1 year. Patients
Externí odkaz:
https://doaj.org/article/a5e700fd004046b78cfd4746ee02b1ad
Autor:
Luis F López-Cortés, Manuel A Castaño, Miguel A López-Ruz, María J Rios-Villegas, José Hernández-Quero, Dolores Merino, Patricia Jiménez-Aguilar, Manuel Marquez-Solero, Alberto Terrón-Pernía, Francisco Tellez-Pérez, Pompeyo Viciana, Francisco Orihuela-Cañadas, Zaira Palacios-Baena, David Vinuesa-Garcia, Jose M Fajardo-Pico, Alberto Romero-Palacios, Guillermo Ojeda-Burgos, Juan Pasquau-Liaño
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148924 (2016)
BACKGROUND AND OBJECTIVE:Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to treat patients that have not experienced previous virological failu
Externí odkaz:
https://doaj.org/article/68978ecd16e8457abeccfd431b980b4a
Autor:
Laura Morata Ruiz, Alessandro Ruggieri, Marco Falcone, Juan Pasquau Liaño, Ivan Gentile, Miguel Salavert Lletí, Leonor Moreno Núñez, Antonio Cascio, Carlo Tascini, Maria Loeches Yagüe, Francesco Giuseppe De Rosa, Alessandra Ori, Alessandro Comandini, Agnese Cattaneo, Paolo Antonio Grossi
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 36, Iss , Pp 200-209 (2024)
Objectives: To retrospectively describe the patterns of use of dalbavancin for treating infections in diabetic patients in Italian and Spanish standard clinical practice. Methods: DALBADIA [NCT04959799] was a multicentre, observational, retrospective
Externí odkaz:
https://doaj.org/article/2e23e12e4a3045e091cbc102aeb40ba9
Autor:
Carmen Hidalgo-Tenorio, Mar Rivero-Rodriguez, Concepción Gil-Anguita, Mercedes Lopez De Hierro, Pablo Palma, Jessica Ramírez-Taboada, Javier Esquivias, Miguel Angel López-Ruz, Rosario Javier-Martínez, Juan Pasquau-Liaño
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92376 (2014)
Chronic infection with oncogenic HPV genotype is associated with the development of anal dysplasia. Antiretroviral therapy (ART) has been shown to decrease the incidence of cervical carcinoma in women with HIV. We sought to: 1) describe the prevalenc
Externí odkaz:
https://doaj.org/article/8a1746208e7c45109830deaa360ae1b7
Autor:
Pilar Retamar-Gentil, Rafael Cantón, Vicente Abril López de Medrano, José Barberán, Andrés Canut Blasco, Carlos Dueñas Gutiérrez, Carolina García-Vidal, Nieves Larrosa Escartín, Jaime Lora-Tamayo, Francisco Javier Martínez Marcos, Carlos Martín Ruíz, Juan Pasquau Liaño, Pedro Rascado, Óscar Sanz Peláez, Genoveva Yagüe Girao, Juan P. Horcajada
Background. Antibiotic resistance in Gram-negative bacilli poses a serious problem for public health. In hospitals, in addition to high mortality rates, the emergence and spread of resistance to practically all antibiotics restricts therapeutic optio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8708c1fe6bc7659665fdceb1f56afc7
http://hdl.handle.net/10230/57276
http://hdl.handle.net/10230/57276
Autor:
Svetlana, Sadyrbaeva-Dolgova, Ricardo, García-Fumero, Manuela, Exposito-Ruiz, Juan, Pasquau-Liaño, Alberto, Jiménez-Morales, Carmen, Hidalgo-Tenorio
Colistimethate sodium (CMS) is the inactive prodrug of colistin, CMS has a narrow antibacterial spectrum with concentration-dependent bactericidal activity against multidrug-resistant gram-negative bacteria, including Pseudomonas aeruginosa and Acine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85bf530e7de96749543df479d2fc1b2a
https://hdl.handle.net/10668/19626
https://hdl.handle.net/10668/19626
Autor:
Manuela Expósito-Ruiz, Svetlana Sadyrbaeva-Dolgova, Carmen Hidalgo-Tenorio, Miguel Ángel Calleja Hernández, Pilar Aznarte-Padial, Juan Pasquau-Liaño
Publikováno v:
International Journal of Infectious Diseases, Vol 85, Iss, Pp 80-87 (2019)
Objective: The aim of this study was to evaluate the safety and efficacy of de-escalation in patients under treatment with carbapenems and its impact on clinical outcomes. Methods: A prospective observational study was conducted for 1 year. Patients
Autor:
Miguel Salavert Lletí, Mireia Mensa Vendrell, Laura Ruiz, Ester López Suñé, Josep Mensa Pueyo, Sergio Sequera Arquelladas, Maria Rosa Oltra Sempere, José Ramón Yuste Ara, Juan Pasquau Liaño, Valentina Isernia, Leonor Moreno Nuñez, Eva Calabuig Muñoz, Alex Soriano Viladomiu, María Tasias Pitarch, Maria-Luisa Pedro-Botet Montoya, Genís Castells Lao, Esteban Alberto Reynaga Sosa
Publikováno v:
Antimicrob Agents Chemother
Tedizolid has demonstrated its efficacy and safety in clinical trials; however, data concerning its tolerability in long-term treatments are scarce. The aim of the study was to assess the indications and to describe the long-term safety profile of te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8e00dc35c52cdfb6d83085eac39119
https://hdl.handle.net/10668/15398
https://hdl.handle.net/10668/15398
Autor:
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Andrea Antinori, Roberto Ortiz, Amanda E Clarke, Chien-Ching Hung, Jürgen K Rockstroh, Pierre-Marie Girard, Jörg Sievers, Choy Man, Alexander Currie, Mark Underwood, Allan R Tenorio, Keith Pappa, Brian Wynne, Anna Fettiplace, Martin Gartland, Michael Aboud, Kimberly Smith, Lidia Cassetti, Daniel David, Laura Figueras, Marcelo Losso, Gustavo Lopardo, Sergio Lupo, Norma Porteiro, Marisa Sánchez, Mark Bloch, David Cooper, Robert Finlayson, Anthony Kelleher, Kenneth Koh, David Lewis, James McMahon, Richard Moore, Norman Roth, Matthew Shields, Stephane De Wit, Eric Florence, Jean-Christophe Goffard, Remy Demeester, Patrick Lacor, Bernard Vandercam, Linos Vandekerckhove, Jonathan Angel, Jean-Guy Baril, Brian Conway, Alexandra De Pokomandy, Jason Szabo, Sharon Walmsley, Olivier Bouchaud, Christian Chidiac, Pierre Delobel, Cecile Goujard, Christine Katlama, Jean-Michel Molina, Gilles Pialoux, Patrick Philibert, Johannes Bogner, Stefan Esser, Ivanka Krznaric, Clara Lehmann, Christoph Spinner, Hans-Jurgen Stellbrink, Christoph Stephan, Albrecht Stoehr, Enrico Barchi, Pietro Caramello, Francesco Castelli, Anna Maria Cattelan, Antonella D'Arminio Monforte, Antonio Di Biagio, Giovanni Di Perri, Andrea Gori, Franco Maggiolo, Barbara Menzaghi, Guglielmo Migliorino, Cristina Mussini, Giovanni Penco, Massimo Puoti, Giuliano Rizzardini, Roberto Gulminetti, Adriano Lazzarin, Tiziano Quirino, Laura Sighinolfi, Pierluigi Viale, Gerardo Amaya Tapia, Jaime Andrade Villanueva, Enrique R Granados Reyes, Alma Perez Rios, Mario Santoscoy Gomez, Jan Den Hollander, Bart Rijnders, José A Hidalgo, Luis Hercilla Vasquez, Luis Illescas, Anita Olczak, Kamal Mansinho, Patricia Paula Correia Pacheco, Eugénio Teófilo, Jose Saraiva da Cunha, Rui Sarmento e Castro, Rosário Serrão, Manuela Arbune, Cristian Jianu, Anca Oprea, Liliana Preotescu, Liviu-Jany Prisacariu, Elena Belonosova, Olga Borodkina, Oxana Chernova, Natalia Gankina, Svetlana Kizhlo, Valeriy Kulagin, Nadezhda Kurina, Firaya Nagimova, Vadim Pokrovsky, Elena Ryamova, Evgeny Voronin, Alexey Yakovlev, Richard Kaplan, Sun Hee Lee, Shin-Woo Kim, Sang-Il Kim, Woo Joo Kim, Antonio Antela Lopez, Jose L Casado Osorio, Manuel A Castaño Carracedo, Ignacio De Los Santos Gil, Vicente Estrada Perez, Vicenç Falco Ferrer, Luis Force, Maria Jose Galinda Puerto, Miguel Garcia Deltoro, Josep M Gatell, Miguel A Goenaga Sanchez, Ana González Cordón, Hernando Knobel, Juan Carlos Lopez Bernaldo de Quiros, Juan E Losa Garcia, Mar Masia, Marta Montero-Alsonso, Antonio Ocampo Hermida, Juan Pasquau Liaño, Joaquin Portilla Sogorb, Federico Pulido Ortega, Antonio Rivera Roman, Jose Ramon Santos Fernandez, Rafael Torres Perea, Jesus Troya Garcia, Pompeyo Viciana Fernandez, Alexandra Calmy, Christoph Hauser, Jan Fehr, Shu-Hsing Cheng, Wen-Chien Ko, Hsi-Hsun Lin, Po-Liang Lu, Yu-Ting Tseng, Ning-Chi Wang, Wing-Wai Wong, Chia-Jui Yang, Roberto Arduino, Paul Benson, Mezgebe Berhe, Fritz Bredeek, Cynthia Brinson, Thomas Campbell, Gordon Crofoot, Douglas Cunningham, Edwin DeJesus, Robin Dretler, Joseph Eron, Kenneth Fife, Carl Fichtenbaum, Jason Flamm, Deborah Goldstein, Samir Gupta, Debbie Hagins, Margaret Hoffman-Terry, Dushyantha Jayaweera, Clifford Kinder, Daniel Klein, Cheryl McDonald, Anthony Mills, Ronald Nahass, Olayemi Osiyemi, Edgar Overton, David Parks, David Prelutsky, Moti Ramgopal, Shannon Schrader, Beverly Sha, Gary Simon, James Sims, Daniel Skiest, Jihad Slim, Karen Tashima, Blair Thedinger, Brian Gazzard, Julie Fox, Margaret Johnson, Stephen Kegg, Saye Khoo, Charles Mazhude, Chloe Orkin, Gabriel Schembri, Andrew Ustianowski
Publikováno v:
The Lancet, 393(10167), 143-155. Elsevier Ltd.
Summary Background Effective two-drug regimens could decrease long-term drug exposure and toxicity with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and safety of a two-drug regimen compared with a three-drug regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad70b60db548619c808fac0879d6106
https://hdl.handle.net/11380/1221490
https://hdl.handle.net/11380/1221490